Related Experiment Video

Updated: Jun 3, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2

Rikke Bæk Sørensen1, Tania Køllgaard, Rikke Sick Andersen

  • 1Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.

Cancer Research
|March 17, 2011
PubMed

Insights

Indoleamine 2,3-dioxygenase (IDO) 2 is expressed in human tumors and may drive immune escape. Researchers found T cells that target and kill IDO2-expressing tumor cells, suggesting IDO2 as a potential cancer immunotherapy target.

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Indoleamine 2,3-dioxygenase (IDO)-like protein 2 (IDO2) expression is observed in various human tumors, including renal, gastric, colon, and pancreatic cancers.
  • Selective inhibition of IDO2 by D-1-methyl-tryptophan (D-1MT) suggests its role in tumor immune escape and growth, with D-1MT enhancing chemotherapy efficacy in preclinical cancer models.

Purpose of the Study:

  • To investigate the immunogenicity of IDO2.
  • To determine if IDO2-specific T cells can recognize and eliminate tumor cells.
  • To evaluate IDO2 as a potential target for cancer immunotherapy.

Main Methods:

  • Analysis of spontaneous cytotoxic T-cell reactivity against IDO2 in peripheral blood from healthy donors and cancer patients.
  • Characterization of IDO2-specific T cells for their cytotoxic effector function against tumor cells.

Main Results:

  • Spontaneous cytotoxic T-cell reactivity against IDO2 was detected in both healthy individuals and cancer patients.
  • IDO2-specific T cells demonstrated the ability to recognize and kill tumor cells.
  • These findings highlight the immunogenicity of IDO2.

Conclusions:

  • IDO2 elicits an immune response, as evidenced by the presence of IDO2-specific T cells.
  • IDO2-specific T cells possess cytotoxic activity against tumor cells.
  • IDO2 represents a promising target for the development of novel anticancer immunotherapeutic strategies.

More Related Videos

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers13:10

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers

Published on: August 1, 2014

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures10:38

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures

Published on: May 9, 2020

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.